1-1 of 1
J. Mangel
Close
Sort by
Journal Articles

Rituximab + ESHAP as Salvage Chemotherapy for Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma: A Phase II Trial.

Lisa Hicks, R. Buckstein, E. Piliotis, J. Mangel, K. Imrie, D. E. Spaner, M. D. Reis, C. Foden, V. Milliken, A. Boudreau, P. Richardson, N. Pennell, N. Berinstein
Journal: Blood
Blood (2004) 104 (11): 5230.
https://doi.org/10.1182/blood.V104.11.5230.5230
Published: 2004